125 related articles for article (PubMed ID: 34657878)
1. Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer.
You Y; Hu S
Cancer Biomark; 2022; 34(1):55-66. PubMed ID: 34657878
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
You Y; Li H; Qin X; Ran Y; Wang F
Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
[TBL] [Abstract][Full Text] [Related]
3. Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.
Chen JY; Wu X; Hong CQ; Chen J; Wei XL; Zhou L; Zhang HX; Huang YT; Peng L
Clin Transl Oncol; 2017 Jan; 19(1):84-90. PubMed ID: 27119734
[TBL] [Abstract][Full Text] [Related]
4. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
5. Esophageal cancer-related gene 4 inhibits gastric cancer growth and metastasis by upregulating Krüppel-like factor 2 expression.
Li X; Hu S; Ma M; Wang P; Qi Y; Zhou Y; Zhong Z; Gao H; Bai F
Ann Transl Med; 2023 Feb; 11(4):176. PubMed ID: 36923086
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-196b promotes gastric cancer progression by targeting ECRG4.
Chen L; Tang H; Liu G; Xiao S; Liang D; Ma J; Yang Y; Luo H; Zhu Y; Xie F; Cheng X; Chi J; Wu X
Anticancer Drugs; 2021 Feb; 32(2):127-137. PubMed ID: 33417325
[TBL] [Abstract][Full Text] [Related]
7. Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation.
Luo L; Wu J; Xie J; Xia L; Qian X; Cai Z; Li Z
Tumour Biol; 2016 Jan; 37(1):1121-9. PubMed ID: 26276361
[TBL] [Abstract][Full Text] [Related]
8. Expression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma.
Wen Y; Hu X
Int J Clin Exp Pathol; 2015; 8(11):14772-8. PubMed ID: 26823803
[TBL] [Abstract][Full Text] [Related]
9. Downregulation and DNA methylation of ECRG4 in gastric cancer.
Deng P; Chang XJ; Gao ZM; Xu XY; Sun AQ; Li K; Dai DQ
Onco Targets Ther; 2018; 11():4019-4028. PubMed ID: 30034241
[TBL] [Abstract][Full Text] [Related]
10. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
[TBL] [Abstract][Full Text] [Related]
11. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
12. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
[TBL] [Abstract][Full Text] [Related]
13. The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma.
Li L; Zhang C; Li X; Lu S; Zhou Y
J Exp Clin Cancer Res; 2010 Oct; 29(1):133. PubMed ID: 20937111
[TBL] [Abstract][Full Text] [Related]
14. Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells.
Matsuzaki J; Torigoe T; Hirohashi Y; Tamura Y; Asanuma H; Nakazawa E; Saka E; Yasuda K; Takahashi S; Sato N
Pathol Int; 2013 Aug; 63(8):391-7. PubMed ID: 23957914
[TBL] [Abstract][Full Text] [Related]
15. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
Zhao XF; Yang YS; Park YK
Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.
Sabatier R; Finetti P; Adelaide J; Guille A; Borg JP; Chaffanet M; Lane L; Birnbaum D; Bertucci F
PLoS One; 2011; 6(11):e27656. PubMed ID: 22110708
[TBL] [Abstract][Full Text] [Related]
17. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance.
Wang YB; Ba CF
Hepatogastroenterology; 2012 Sep; 59(118):1696-8. PubMed ID: 22626786
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.
Li LW; Li YY; Li XY; Zhang CP; Zhou Y; Lu SH
BMC Cancer; 2011 Feb; 11():52. PubMed ID: 21288367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
